Coherus Oncology (8C5.F) Q1 2026 Earnings

9MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.37
-0.31
-0.25
-0.19

Details

Expected EPS
-0.30542098130999995
Actual EPS
-0.3354507
Surprise EPS
-0.03
Surprise Percent
+9.83%

Description

Coherus Oncology (8C5.F) has reported earnings of -0.3354507 per share for Q1 2026.

0 Comments

Share your thoughts